First Time Loading...

Celldex Therapeutics Inc
NASDAQ:CLDX

Watchlist Manager
Celldex Therapeutics Inc Logo
Celldex Therapeutics Inc
NASDAQ:CLDX
Watchlist
Price: 38.21 USD -4.33% Market Closed
Updated: May 18, 2024

Celldex Therapeutics Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celldex Therapeutics Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Celldex Therapeutics Inc
NASDAQ:CLDX
Interest Income Expense
$13.1m
CAGR 3-Years
76%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-19%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$757m
CAGR 3-Years
35%
CAGR 5-Years
0%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.9B
CAGR 3-Years
-44%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$563.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$221.8m
CAGR 3-Years
-13%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is Celldex Therapeutics Inc's Interest Income Expense?
Interest Income Expense
13.1m USD

Based on the financial report for Dec 31, 2023, Celldex Therapeutics Inc's Interest Income Expense amounts to 13.1m USD.

What is Celldex Therapeutics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
24%

Over the last year, the Interest Income Expense growth was 351%. The average annual Interest Income Expense growth rates for Celldex Therapeutics Inc have been 76% over the past three years , 24% over the past five years .